Kymera Therapeutics
KYMR
KYMR
210 hedge funds and large institutions have $3.44B invested in Kymera Therapeutics in 2025 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 69 increasing their positions, 51 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
35% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 51
22% more funds holding
Funds holding: 172 → 210 (+38)
8.89% more ownership
Funds ownership: 112.12% → 121.01% (+8.9%)
Holders
210
Holding in Top 10
13
Calls
$10.1M
Puts
$3.16M
Top Buyers
| 1 | +$35.2M | |
| 2 | +$30.9M | |
| 3 | +$25.8M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$22.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$17.8M |
Top Sellers
| 1 | -$25.9M | |
| 2 | -$21.5M | |
| 3 | -$15.6M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$11.8M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$8.09M |